Dr. Weisman knows how to bridge the gap between science and marketing. As head of ISS’s Clinical and Regulatory Support practice, he focuses on the development of scientific and regulatory approaches that increase a product’s market potential. He’s an invaluable resource for scientific litigation support for products in crisis and, under his guidance, ISS has encouraged firms to proactively monitor the safety and effectiveness of their products and develop systems that reduce liability claims. Dr. Weisman has over 20 years of experience in pharmacology, toxicology, pharmaceutical product development, clinical and regulatory affairs, and marketing evaluation and communication.
This person is not in the org chart
This person is not in any teams